Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Amortizatization of Intangibles came in at $347000.0 in Q1 2026, up 1926.32% year-on-year from $17124.7 in Q1 2025, and down 58.24% on a QoQ basis from $831000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 4 years of Amortizatization of Intangibles data on file, last reported at $347000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 1926.32% year-over-year to $347000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 120.12% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 17.37% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $347000.0, down from $831000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for WHWK reached as high as $1.2 million in Q1 2023 and fell as low as -$19000.0 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $485461.5 across 4 years, with a median of $422000.0 in 2024.
- Across the five-year window, Amortizatization of Intangibles sank 104.5% in 2025 and jumped 1926.32% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $486000.0 in 2023, then slumped by 62.35% to $183000.0 in 2024, then surged by 354.1% to $831000.0 in 2025, then tumbled by 58.24% to $347000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $347000.0 in Q1 2026, $831000.0 in Q4 2025, and $717000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | 347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 347,000.00 |
| Mar 31, 2026 | 347,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Dec 31, 2023 | 486,000.00 |